- Nachrichtendetail
-
13.05.2024 07:39:16 - dpa-AFX: *REGENERON: FDA ACCEPTS FOR PRIORITY REVIEW SBLA FOR DUPIXENT FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPOSIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 96,460 | 25.07.24 10:55:44 | +2,870 | +3,07% | 96,390 | 96,460 | 95,990 | 93,590 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 976,000 | 25.07.24 08:09:59 | -0,600 | -0,06% | 978,000 | 984,000 | 976,000 | 976,600 |
